HIMS Investors Urged to Lead Hims & Hers Securities Fraud Lawsuit

The Schall Law Firm, a national shareholder rights litigation firm, has alerted investors to a class action lawsuit filed against Hims & hers Health, Inc. (NYSE: HIMS).

The lawsuit alleges violations of federal securities laws, specifically Sections 10(b) and 20(a) of the Securities exchange Act of 1934 and Rule 10b-5. These are common charges in cases where investors believe a company’s public statements were misleading.

Investors who bought Hims & Hers securities between April 29, 2025, and June 23, 2025, are encouraged to contact the firm.The deadline to participate in the class action lawsuit is August 25, 2025.

Historically, class action lawsuits like this often stem from allegations of inflated stock prices due to false or misleading statements about a company’s financial health, buisness prospects, or regulatory compliance. Such cases aim to recover losses for investors who were harmed by these alleged misrepresentations.

for those who invested in Hims & Hers during the specified period, understanding the details of the lawsuit and consulting with legal counsel is a crucial step. This allows investors to assess their potential involvement and the implications for their investment.

this article is for informational purposes only and does not constitute financial or legal advice. Investors are encouraged to consult with their own legal and financial professionals.

Did Hims & Hers allegedly misrepresent its adherence to healthcare regulations?

understanding the Allegations: Hims & Hers Stock Fraud

Investors who purchased shares of Hims & Hers Health,Inc. (NYSE: HIMS) between May 11, 2023, and July 18, 2023, are being urged to step forward as lead plaintiffs in a securities class action lawsuit. The lawsuit alleges that hims & Hers made materially false and misleading statements regarding its business, operational results, and compliance with regulations. Specifically, the claims centre around alleged inaccuracies in the company’s reporting of prescription volumes and revenue recognition practices.This potential securities fraud has led to significant losses for investors.

Key Claims in the hims & Hers Lawsuit

The core of the lawsuit revolves around accusations that Hims & Hers misrepresented its growth trajectory and financial health to the public. Here’s a breakdown of the key allegations:

Inflated Prescription Volumes: Plaintiffs allege that Hims & Hers overstated the number of prescriptions fulfilled, creating a false impression of demand for its products and services.

Improper Revenue Recognition: The lawsuit claims the company improperly recognized revenue, accelerating income and misleading investors about its true financial performance.

misleading Statements Regarding Compliance: allegations suggest Hims & Hers misrepresented its adherence to relevant healthcare regulations and industry standards.

Lack of Internal Controls: The suit points to potential weaknesses in the company’s internal controls over financial reporting, contributing to the alleged misstatements.

These alleged misrepresentations resulted in an artificial inflation of HIMS stock price. When the truth began to emerge, the stock experienced a significant decline, causing substantial financial harm to investors.

who is Eligible to Join the Hims & Hers Securities Fraud Lawsuit?

If you meet all of the following criteria, you might potentially be eligible to participate in the lawsuit:

Purchased HIMS stock: You purchased shares of Hims & Hers Health, Inc. (HIMS) on the open market.

Purchase Dates: Your purchases occurred between May 11, 2023, and July 18, 2023 (the “Class Period”).

Suffered Losses: You incurred losses consequently of the decline in HIMS stock price following the disclosure of the alleged misstatements.

Critically important Note: Eligibility is resolute by the court, not by simply meeting these criteria.

Lead Plaintiff Deadline & What it Means

The court has set a deadline for investors to petition to be appointed as lead plaintiff. This role is crucial as the lead plaintiff is responsible for actively directing the litigation on behalf of the class.

Deadline: Typically, the deadline to file a motion for lead plaintiff status is approximately 60 days after the lawsuit is filed. It is indeed crucial to verify the exact deadline with legal counsel.

Lead Plaintiff Responsibilities: The lead plaintiff, with the assistance of appointed counsel, will oversee the litigation process, including finding, depositions, and potential settlement negotiations.

Benefits of Lead Plaintiff Status: While demanding, being the lead plaintiff can offer greater influence over the litigation and possibly a larger share of any recovery.

Potential Damages & Recovery Options

Investors who suffered losses due to the alleged fraud may be entitled to recover damages, including:

lost Investment Funds: Reimbursement for the difference between the price you paid for HIMS stock and the price it traded at after the revelations of the alleged fraud.

Incidental Damages: Other financial losses directly related to the decline in stock price.

Legal fees: In some cases, recovery of legal fees associated with participating in the lawsuit.

The amount of recovery will depend on the outcome of the litigation and the extent of the damages proven.

Why Investors are Being Urged to act Now

Time is of the essence. The deadline to petition for lead plaintiff status is rapidly approaching.Investors who believe they have been harmed by the alleged fraud should:

1. Consult with Securities Litigation Attorneys: Experienced attorneys specializing in securities class action lawsuits can assess your eligibility, explain your rights, and guide you through the process.
2. Gather Documentation: Collect all relevant documentation, including brokerage statements, purchase confirmations, and any communications related to Hims & Hers.
3. File a Motion for Lead Plaintiff Status (if desired): If you meet the criteria and are interested in becoming the lead plaintiff, your attorney can prepare and file the necessary motion with the court.

Resources for Hims & Hers Investors

Securities and Exchange Commission (SEC): https://www.sec.gov/ – Provides information about securities regulations and enforcement actions.

FINRA (Financial Industry Regulatory Authority): https://www.finra.org/ – Offers investor education resources and dispute resolution services.

Legal News Websites: Stay informed about the latest developments in the Hims & Hers lawsuit through reputable legal news sources.

Disclaimer: This article is for informational purposes only and does not constitute legal advice. You should consult with a qualified attorney to discuss your specific situation.